Valuation: Fagron N.V.

Market Cap 1.79B 1.99B 1.65B 1.49B 2.83B 187B 2.91B 19.71B 7.85B 100B 7.47B 7.32B 316B P/E 2026 *
17.3x
P/E 2027 * 15x
Enterprise Value 2.29B 2.56B 2.11B 1.92B 3.63B 240B 3.73B 25.3B 10.08B 128B 9.6B 9.39B 406B EV / Sales 2026 *
2.02x
EV / Sales 2027 * 1.8x
Free-Float
71.38%
Yield 2026 *
1.74%
Yield 2027 * 1.86%
1 week+1.67%
Current month+3.84%
1 month+8.71%
3 months+8.46%
6 months+1.88%
Current year+14.32%
1 week 23.9
Extreme 23.9
24.8
1 month 22.2
Extreme 22.2
24.8
Current year 20.85
Extreme 20.85
25.3
1 year 20
Extreme 20
25.3
3 years 15.14
Extreme 15.14
25.3
5 years 10.8
Extreme 10.8
25.3
10 years 8.2
Extreme 8.2
25.3
Manager TitleAgeSince
Chief Executive Officer 48 27/11/2017
Director of Finance/CFO 47 01/05/2016
Chief Operating Officer 54 09/05/2022
Director TitleAgeSince
Director/Board Member 47 01/05/2016
Chairman 58 09/05/2017
Director/Board Member 48 07/02/2018
Date Insider Type Main position Quantity % Market Cap. Importance
5/28/25 A Buy 85,000 0.1161%
5/28/25 A Sell 85,000 0.1161%
5/14/25 A Sell 2,689 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.67%+17.63%+43.49% 1.99B
+1.44%+1.63%+48.17%+139.63% 1,276B
-0.47%+5.49%+49.03%+90.68% 676B
+0.20%+2.76%+34.37%+112.06% 519B
-0.92%+0.73%+38.14%+67.04% 388B
-0.48%+2.34%+70.66%+46.02% 365B
-1.01%-0.77%+28.00%+57.43% 307B
-0.22%-1.24%+2.85%+35.15% 287B
0.00%+0.86%+43.74%+74.04% 252B
+0.92%+2.03%+44.62%+125.07% 212B
Average -0.21%+2.49%+37.72%+79.06% 428B
Weighted average by Cap. -0.24%+2.51%+42.71%+96.50%

Financials

2026 *2027 *
Net sales 1.14B 1.27B 1.05B 951M 1.8B 119B 1.85B 12.54B 5B 63.66B 4.76B 4.66B 201B 1.24B 1.39B 1.15B 1.04B 1.97B 130B 2.03B 13.73B 5.47B 69.72B 5.21B 5.1B 220B
Net income 105M 117M 96.79M 87.9M 166M 10.98B 171M 1.16B 462M 5.88B 439M 430M 18.6B 119M 133M 110M 99.74M 189M 12.46B 194M 1.31B 524M 6.67B 499M 488M 21.1B
Net Debt 507M 565M 467M 424M 803M 53B 825M 5.59B 2.23B 28.4B 2.12B 2.08B 89.77B 448M 500M 413M 375M 710M 46.87B 730M 4.95B 1.97B 25.11B 1.88B 1.84B 79.38B
Projected Income Statement - Annual - Fagron N.V.
Logo Fagron N.V.
Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.
Employees
4,880
Date Price Change Volume
11/11/26 €24.35 0.00% 4,450
10/11/26 €24.35 -1.22% 74,797
09/11/26 €24.65 +1.86% 136,035
06/11/26 €24.20 -0.82% 101,373
05/11/26 €24.40 +1.88% 97,341
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Fagron N.V.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
24.35EUR
Average target price
29.00EUR
Spread / Average Target
+19.10%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Fagron N.V.
  1. Stock Market
  2. Stocks
  3. FAGR Stock